NATAC Logo

NATAC

NAT | BME Growth

Overview

Corporate Details

ISIN(s):
ES0171613005
LEI:
959800CAJAU3LNQW9246
Country:
Spain
Address:
AVA RITA LEVI MONTALCINI 14, 28906 Getafe
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

NATAC is a biotechnology company specializing in the research, development, and sustainable production of plant-based extracts and bioactive ingredients with scientifically proven health benefits. The company develops high-quality, evidence-based solutions for various sectors, including the nutraceutical, pharmaceutical, food, animal feed, and pet nutrition industries. Emphasizing a sustainable and intelligent manufacturing model, NATAC guarantees botanical identity and quality, complying with European standards. With a global distribution network supported by offices in Europe, the United States, and Singapore, the company offers its natural ingredients and technical support to a worldwide clientele.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for NATAC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all NATAC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for NATAC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Vivesto Logo
Develops therapies for hard-to-treat cancers in human and veterinary oncology.
Sweden VIVE
WAKAMOTO PHARMACEUTICAL CO.,LTD. Logo Japan 4512
Xbrane Biopharma Logo
Develops affordable biosimilars for serious diseases using patented, high-yield production tech.
Sweden XBRANE
Xspray Pharma Logo
Develops improved PKI cancer drugs using patented amorphous tech for earlier market entry.
Sweden XSPRAY
Y.B Urban Renewal - Residential Development LTD Logo Israel CSURE-M
YUKI GOSEI KOGYO CO.,LTD. Logo Japan 4531
Zelluna ASA Logo
Developing off-the-shelf TCR-NK cell therapies to treat patients with solid cancers.
Norway ULTI
Zentiva 2 Logo
Develops and commercializes affordable generic, OTC, and biosimilar medicines for patients.
Slovakia SKF
Zentiva S.A. Logo
Develops and distributes affordable generic, OTC, and specialty medicines across Europe.
Romania SCD
ZERIA PHARMCEUTICAL CO., LTD. Logo Japan 4559